Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1989-12-28 to 1990-01-11
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1990

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Reference
Name:
Unnamed
Type:
Constituent
Details on test material:

- Substance type: UVCB
- Physical state: solid
- Composition of test material, percentage of components: cettearyl alcohol 80% and cetearyl glucoside 20%
- Storage condition of test material: in hermetically stoppered glass flask and stored at room temperature

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
rats 12 months old at the beginning of the study.
5 males: 182.2+/- 4.4 g
5 females: 177. 4 +/-5.4g

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Amount of vehicle (if gavage): 10ml/kg
- Justification for choice of vehicle:the product is a cristallin salt so the water is sufficient as vehicule



MAXIMUM DOSE VOLUME APPLIED: 2g/kg
Doses:
2g/kg
No. of animals per sex per dose:
5 females and 5 males
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:during the 3 hours following the administration, tha animals were quasi continiously observed. during the following 14 days, a daily observation was made.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Sex:
male/female
Dose descriptor:
LDLo
Effect level:
> 2 000 mg/kg bw
Sex:
male/female
Dose descriptor:
other: NOEL acute oral systemic
Effect level:
ca. 2 000 mg/kg bw
Sex:
male/female
Dose descriptor:
other: NOEC acute oral local
Effect level:
ca. 2 000 mg/kg bw
Mortality:
no deaths were recorded
Clinical signs:
no sign evidencing any toxicity at the level of the central nervous system or neuro vegetative system was noted
Body weight:
the weight increase of male and femalae animals was normal comparable to that of animals from this strain

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Under the experimental conditions employed, the chemical failed to lead any mortality.
The autopsy of the animals at the end of the trial failed to evidence any necroscopic lesions that could be related to toxic effect of the product.
The minimal lethal dose of the product is therefore greater than 2 g/kg in the Sprague Dawley rat, when administered in a single oral dose.
Executive summary:

The substance was given in a single oral administration, at the dose of 2g/kg, to 5 male rats and 5 female rats, according to the protocol recommended by the guidelines OECD (n° 401 dated 24.02.1987).

From the results of this trial , it can be conclude that, under the experimental conditions employed, the minimal lethal dose of the substance is above 2g/kg.